Indian drug company counter-sues AstraZeneca Covid-19 jab volunteer for ‘malicious’ claim vaccine trial led to health issues ...News

The Serum Institute of India (SII), the world’s largest vaccine manufacturer, has gone on the offensive after a participant in its coronavirus vaccine trial sued the firm, alleging he suffered serious side effects from the jab. In a countersuit, SII has demanded Rs 100 crore ($13.5 million USD) from the volunteer for his “malicious and misconceived” allegation that Covishield, a version of the AstraZeneca-Oxford University Covid-19 jab, led to a medical episode. Read more Participant in India’s AstraZeneca Covid-19 vaccine trial sues after experiencing ‘severe adverse effect’

Hence then, the article about indian drug company counter sues astrazeneca covid 19 jab volunteer for malicious claim vaccine trial led to health issues was published today ( Monday 30/11/2020 - 12:31 PM ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indian drug company counter-sues AstraZeneca Covid-19 jab volunteer for ‘malicious’ claim vaccine trial led to health issues )

Also on site :

• The Supreme Court Cast Its Lot With Trumpism. It Should Be Very Worried.
• UN renews Sudan ceasefire appeal over ‘unimaginable suffering’ of civilians
• Central African Republic election: Who’s running and what’s at stake?